Human Metabolome Technologies, Inc. announced consolidated earnings results for the second quarter ended December 2019. For the period, the company reported net sales of JPY 454 million, operating loss was JPY 123 million, loss attributable to the owners of parent was JPY 118 million and basic loss per share was JPY 20.26.

For the year ending June 30, 2020, the company expects consolidated net sales to be JPY 920 million, operating loss to be JPY 300 million, loss attributable to owners of parent to be JPY 302 million and basic loss per share to be JPY 51.59.